Elevation Oncology, Inc. (ELEV) Marketable Securities, Current USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Elevation Oncology, Inc. quarterly Marketable Securities, Current history and growth rate from 2021 to 2024.
  • Elevation Oncology, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $13.4 M, a 25.6% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $13.4 M -$4.61 M -25.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $33.9 M -$10.5 M -23.7% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 $39.9 M -$15.4 M -27.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.6 M -$67.1 M -97.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $18 M -$61 M -77.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $44.4 M +$44.4 M Dec 31, 2022 10-K 2024-03-06
Q3 2022 $55.3 M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $68.7 M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $79.1 M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.